保守氧疗在重症肺炎机械通气患者中的疗效观察
该研究为前瞻性随机对照研究,纳入2019年5月至2021年5月合肥市第一人民医院ICU收治的110例需机械通气的重症肺炎患者,随机分为常规氧疗组(51例)和保守氧疗组(55例)。两组均采用有创-无创序贯机械通气策略,常规氧疗组目标为动脉血氧分压(PaO2)>150 mmHg或脉搏血氧饱和度(SpO2)>0.96;保守氧疗组目标为PaO2 70-100 mmHg或SpO2 0.90-0.92。结果显示,保守氧疗组pH值显著高于常规氧疗组,PaO2、PaCO2和氧合指数显著低于常规氧疗组,机械通气时间显著延长,但ICU住院时间无显著差异。保守氧疗组ICU死亡率、新发血流感染、肝功能不全、休克和ICU获得性衰弱发生率均显著降低,Kaplan-Meier分析显示累积生存率显著更高。结论认为保守氧疗可减少上述并发症,但延长机械通气时间。
要点
- 保守氧疗组ICU死亡率27.3%(15/55)显著低于常规氧疗组45.1%(23/51),P<0.05。
- 保守氧疗组休克发生率3.6%(2/55)显著低于常规氧疗组9.8%(5/51),肝功能不全1.8%(1/55)显著低于7.8%(4/51),ICUAW 5.5%(3/55)显著低于11.8%(6/51),新发血流感染5.5%(3/55)显著低于11.8%(6/51),均P<0.05。
- 保守氧疗组机械通气时间(19.7±3.5)天显著长于常规氧疗组(13.9±4.5)天,P<0.05;ICU住院时间(26.5±5.0)天与常规氧疗组(25.5±4.6)天无显著差异,P>0.05。
- 保守氧疗组累积生存率72.7%显著高于常规氧疗组54.9%(Log-Rank检验:χ2=4.244,P=0.039)。
- 保守氧疗组pH值7.4±0.1显著高于常规氧疗组7.3±0.3;PaO2(68.9±4.7)mmHg、PaCO2(42.1±5.6)mmHg、氧合指数(329±126)mmHg均显著低于常规氧疗组[分别为(75.2±6.0)mmHg、(50.5±7.5)mmHg、(365±108)mmHg],均P<0.05。
适用人群与场景
- 2019年5月至2021年5月合肥市第一人民医院ICU收治的需机械通气的重症肺炎患者110例,随机分为常规氧疗组51例和保守氧疗组55例。
诊断标准与关键阈值
- 常规氧疗组氧疗目标:PaO2>150 mmHg或SpO2>0.96;保守氧疗组氧疗目标:PaO2 70-100 mmHg或SpO2 0.90-0.92。
处置流程与药物剂量
- 两组均采用有创-无创序贯机械通气策略。
- 常规氧疗组:氧疗目标为PaO2>150 mmHg或SpO2>0.96。
- 保守氧疗组:氧疗目标为PaO2 70-100 mmHg或SpO2 0.90-0.92。
研究设计与关键结果
- 研究类型:前瞻性随机对照研究;样本量110例(常规氧疗组51例,保守氧疗组55例);单中心(合肥市第一人民医院ICU);人群为需机械通气的重症肺炎患者。
- 干预与对照:两组均采用有创-无创序贯机械通气策略,保守氧疗组目标PaO2 70-100 mmHg或SpO2 0.90-0.92,常规氧疗组目标PaO2>150 mmHg或SpO2>0.96。
- 主要终点结果:保守氧疗组ICU死亡率27.3%(15/55)显著低于常规氧疗组45.1%(23/51),P<0.05。
- 关键次要终点:保守氧疗组机械通气时间(19.7±3.5)天显著长于常规氧疗组(13.9±4.5)天,P<0.05;ICU住院时间(26.5±5.0)天与常规氧疗组(25.5±4.6)天无显著差异,P>0.05。
- 不良事件:保守氧疗组新发血流感染5.5%(3/55)显著低于常规氧疗组11.8%(6/51),肝功能不全1.8%(1/55)显著低于7.8%(4/51),休克3.6%(2/55)显著低于9.8%(5/51),ICU获得性衰弱5.5%(3/55)显著低于11.8%(6/51),均P<0.05。
- Kaplan-Meier分析:保守氧疗组累积生存率72.7%显著高于常规氧疗组54.9%(Log-Rank检验:χ2=4.244,P=0.039)。
证据类型、等级与局限
- 证据类型:前瞻性随机对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,保守氧疗可降低重症肺炎机械通气患者的ICU死亡率、休克、肝功能不全、ICU获得性衰弱和血流感染发生率,但延长机械通气时间。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare the effects of conservative oxygen therapy and conventional oxygen therapy on the efficacy and prognosis of mechanical ventilation support in patients with severe pneumonia.
METHODS: A prospective randomized controlled study were conducted, 110 patients with severe pneumonia requiring mechanical ventilation in intensive care unit (ICU) of Hefei First People's Hospital from May 2019 to May 2021 were selected and divided into conventional oxygen therapy group (51 cases) and conservative oxygen therapy group (55 cases) according to random number table method. Patients in both groups were treated with invasive to non-invasive sequential mechanical ventilation strategy, and the target of oxygen therapy in the conventional oxygen therapy group was set as the arterial partial pressure of oxygen (PaO2) > 150 mmHg (1 mmHg = 0.133 kPa) or pulse oxygen saturation (SpO2) > 0.96. In the conservative oxygen therapy group, PaO2 was set at 70-100 mmHg or SpO2 at 0.90-0.92. The changes of blood gas analysis, mechanical ventilation time, ICU stay time, ICU mortality, new organ dysfunction and infection more than 48 hours after admission were observed in two groups before and after treatment. Kaplan-Meier method was used to analyze the difference in cumulative survival rate between the two groups.
RESULTS: After treatment, pH value, PaO2 and oxygenation index (PaO2/FiO2) in both groups were significantly higher than before treatment, and arterial partial pressure of carbon dioxide (PaCO2) was significantly lower than before treatment. pH value in the conservative oxygen therapy group was significantly higher than that in the conventional oxygen therapy group (7.4±0.1 vs. 7.3±0.3). PaO2, PaCO2 and PaO2/FiO2 were significantly lower than those in conventional oxygen therapy group [PaO2 (mmHg): 68.9±4.7 vs. 75.2±6.0, PaCO2 (mmHg): 42.1±5.6 vs. 50.5±7.5, PaO2/FiO2 (mmHg): 329±126 vs. 365±108, all P < 0.05]. The mechanical ventilation time in the conservative oxygen therapy group was significantly longer than that in the conventional oxygen therapy group (days: 19.7±3.5 vs. 13.9±4.5, P < 0.05), but there was no significant difference in ICU hospitalization time between the conservative oxygen therapy group and the conventional oxygen therapy group (days: 26.5±5.0 vs. 25.5±4.6, P > 0.05). Compared with the conventional oxygen therapy group, the ICU mortality, the incidence of nosocomial bloodstream infection, and the incidence of liver insufficiency, shock, and ICU acquired weakness (ICUAW) were decreased significantly in the conservative oxygen therapy group [ICU mortality: 27.3% (15/55) vs. 45.1% (23/51), liver insufficiency: 1.8% (1/55) vs. 7.8% (4/51), shock: 3.6% (2/55) vs. 9.8% (5/51), ICUAW: 5.5% (3/55) vs. 11.8% (6/51), the incidence of new bloodstream infection: 5.5% (3/55) vs. 11.8% (6/51), all P < 0.05]. Kaplan-Meier analysis showed that the cumulative survival rate of the conservative oxygen therapy group was significantly higher than that of the conventional oxygen therapy group (72.7% vs. 54.9%; Log-Rank test: χ2 = 4.244, P = 0.039).
CONCLUSIONS: Conservative oxygen therapy can reduce ICU mortality, the incidence of shock, liver insufficiency, ICUAW, and bloodstream infection in patients with severe pneumonia, but prolong mechanical ventilation time.
参考来源
- Yang W, Zhang L. [Observation of the curative effect of conservative oxygen therapy in mechanical ventilation of patients with severe pneumonia]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34839863. doi:10.3760/cma.j.cn121430-20210617-00902
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。